ERAP1-IN-3
ERAP1-IN-3 (compound 13) is a potent endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitor, with a pIC50 of 8.6. ERAP1-IN-3 has potential for the research of cancer immunotherapy and autoimmune disease[1].
Product Specifications
UNSPSC
12352005
Target
Aminopeptidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/erap1-in-3.html
Smiles
O=C(C1(NC(CN2C(SC3=CC=C(C4=CC=CC=C4)C=C23)=O)=O)CCCCC1)O
Molecular Formula
C22H22N2O4S
Molecular Weight
410.49
References & Citations
[1]Hryczanek RP, et, al. Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug Design. CS Med. Chem. Lett. 2024, 15, 12, 2107-2114.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![DUSP5 Mouse Monoclonal Antibody [Clone ID: OTI1D8]](https://cdn.genprice.uk/products/937/68dd18bb061270361e908a16/imageurl/cf811048.webp)
F-8011-1 1 mg
FITC Conjugated Calystega sepiem Lectin (Hedge Bindweed Rhizomes) -Calsepa-
Sign In for Pricing
View Details 
LY424506 100 µg
GAD65 (GAD2) (NM_000818) Human Over-expression Lysate
Sign In for Pricing
View Details 